{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:08:45Z","timestamp":1776175725530,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Skin Wound Care"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To determine the feasibility of an adequately powered trial testing a long-acting cyanoacrylate skin protectant to prevent incontinence-associated dermatitis in critically ill patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>This open-label pilot randomized controlled feasibility study was conducted in the adult ICU of an Australian quaternary referral hospital. Patients were allocated to either an intervention group or a control group (usual care). The intervention was the application of a skin protectant (a durable, ultra-thin, transparent, waterproof, no-removal barrier film). Data collected by trained research nurses included demographic and clinical variables, skin assessment, and incontinence-associated dermatitis presence and severity. Data were analyzed using descriptive and inferential statistics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Of the 799 patients screened, 85% were eliminated because of a short ICU stay or other exclusion criteria. The mean proportion of patients not meeting any of the exclusion criteria was 22% on each screening day. Protocol fidelity was followed for 90% of intervention participant study days. Retention of participants was 86% (31 participants out of 36), 15 in the intervention group and 16 in the control group. Enrolled patients had a mean age of 59 years, 50% were obese, 67% were male, and 36% were smokers. Two patients (11%) in the intervention group developed incontinence-associated dermatitis, compared with three (17%) in the control group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS<\/jats:title>\n            <jats:p>This study reports no significant findings between the two groups. Difficulty in recruitment and feasibility issues might be overcome with changes to inclusion criteria and study design.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/01.asw.0000666904.35944.a3","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T14:22:14Z","timestamp":1592230934000},"page":"375-382","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy of Incontinence-Associated Dermatitis Intervention for Patients in Intensive Care: An Open-Label Pilot Randomized Controlled Trial"],"prefix":"10.1097","volume":"33","author":[{"given":"Fiona","family":"Coyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Doubrovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib2-20230923","first-page":"327","article-title":"Diarrhoea risk factors in enterally tube fed critically ill patients: a retrospective audit","volume":"6","year":"2010","journal-title":"Intens Crit Care Nurs"},{"key":"bib3-20230923","doi-asserted-by":"crossref","first-page":"24691","DOI":"10.1038\/srep24691","article-title":"Diarrhoea in the critically ill is common, associated with poor outcome, and rarely due to Clostridium difficile","volume":"6","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"bib4-20230923","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/WON.0b013e318220b703","article-title":"Incontinence-associated dermatitis in critically ill adults: time to development, severity, and risk factors","volume":"38","year":"2011","journal-title":"J Wound Ostomy Continence Nurs"},{"issue":"4","key":"bib5-20230923","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4037\/ccn2007.27.4.42","article-title":"Perineal dermatitis in critical care patients","volume":"27","year":"2007","journal-title":"Crit Care Nurs"},{"issue":"4","key":"bib6-20230923","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/nicc.12331","article-title":"Incontinence-associated dermatitis in the critically ill patient: an intensive care perspective","volume":"23","year":"2018","journal-title":"Nurs Crit Care"},{"key":"bib7-20230923","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.iccn.2016.12.001","article-title":"An interventional skin care protocol (InSPiRE) to reduce incontinence-associated dermatitis in intensive care patients; a before and after study","volume":"40","year":"2017","journal-title":"Intens Crit Care Nurs"},{"issue":"5","key":"bib8-20230923","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/wrr.12455","article-title":"In vivo methods to evaluate a new skin protectant for loss of skin integrity","volume":"24","year":"2016","journal-title":"Wound Repair Regen"},{"issue":"2","key":"bib9-20230923","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/WON.0000000000000307","article-title":"Clinical evaluation of a skin protectant for the management of incontinence-associated dermatitis: an open-label, nonrandomized, prospective study","volume":"44","year":"2017","journal-title":"J Wound Ostomy Continence Nurs"},{"issue":"10","key":"bib10-20230923","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease scoring system","volume":"13","year":"1985","journal-title":"Crit Care Med"},{"issue":"7","key":"bib11-20230923","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s001340050931","article-title":"The use of maximum SOFA score to quantify organ dysfunction\/failure in intensive care. Results of a prospective, multicentre study. Working Group of the ESICM on Sepsis Related Problems","volume":"25","year":"1999","journal-title":"Intensive Care Med"},{"issue":"14","key":"bib12-20230923","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","article-title":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","volume":"286","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"bib13-20230923","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","year":"1997","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"bib16-20230923","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/CCM.0000000000001369","article-title":"Premature discontinuation of randomised trials in critical and emergency care: a retrospective cohort study","volume":"44","year":"2016","journal-title":"Crit Care Med"},{"issue":"1","key":"bib17-20230923","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10654-017-0325-0","article-title":"Case-control matching: effects, misconceptions and recommendations","volume":"33","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"bib18-20230923","first-page":"h391","article-title":"The Stepped wedge cluster randomised control trial: rational, design, analysis and reporting","volume":"350","year":"2015","journal-title":"BMJ Res Methods Rep"},{"key":"bib19-20230923","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jtv.2016.02.004","article-title":"A decade of research on incontinence-associated dermatitis (IAD): evidence, knowledge gaps and next steps","volume":"26","year":"2017","journal-title":"J Tissue Viability"},{"issue":"5","key":"bib20-20230923","first-page":"7443","article-title":"Investigation and analysis on occurrence of incontinence-associated dermatitis of ICU patient with fecal incontinence","volume":"10","year":"2017","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"bib21-20230923","first-page":"333","article-title":"Development of perineal dermatitis in critically ill adults with fecal incontinence","volume":"15","year":"2006","journal-title":"Am J Crit Care"},{"issue":"4","key":"bib22-20230923","first-page":"214","article-title":"Prevention of incontinence-related skin breakdown for acute and critical care patients: comparison of two products","volume":"32","year":"2012","journal-title":"Urologic Nurs"},{"key":"bib23-20230923","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijosm.2017.02.001","article-title":"The importance of pilot studies, how to write them and what they mean","volume":"23","year":"2017","journal-title":"Int J Osteopathic Med"}],"container-title":["Advances in Skin &amp; Wound Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ASW.0000666904.35944.a3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T10:29:55Z","timestamp":1695464995000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ASW.0000666904.35944.a3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/01.asw.0000666904.35944.a3","relation":{},"ISSN":["1538-8654","1527-7941"],"issn-type":[{"value":"1538-8654","type":"electronic"},{"value":"1527-7941","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}